Clinical trial
A Randomized, Double-blind, Placebo-controlled, Two-cohort, Three-way Crossover Clinical Trial to Evaluate the Pharmacodynamic Effect of Different Doses of TPN171H Tablets in Mild to Moderate Male Erectile Dysfunction
NCT05388825 is registered in ClinicalTrials.gov with Vigonvita Life Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo-controlled, Two-cohort, Three-way Crossover Clinical Trial to Evaluate the Pharmacodynamic Effect of Different Doses of TPN171H Tablets in Mild to Moderate Male Erectile Dysfunction
- Lead sponsor
- Vigonvita Life Sciences
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 1, 2022
- Completion date
- February 17, 2023
- Enrollment
- 84 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.